John E. Berriman - 18 Mar 2026 Form 3 Insider Report for Autolus Therapeutics plc (AUTL)

Reporting relationship
Director
Issuer ticker
AUTL
Reported as of
18 Mar 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
18 Mar 2026, 19:51:37 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John Berriman

Key filing fact

John E. Berriman filed Form 3 for Autolus Therapeutics plc (AUTL) on 18 Mar 2026.

Key facts

  • This page summarizes John E. Berriman's Form 3 filing for Autolus Therapeutics plc (AUTL).
  • 0 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2026, 19:51.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001291964 Primary reporting owner

Berriman John E

Relationship
Director
Address
C/O AUTOLUS THERAPEUTICS PLC, THE MEDIAWORKS, 191 WOOD LN, WHITE CITY, LONDON, UNITED KINGDOM
Signature
/s/ John Berriman
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AUTL holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
136,331
Date
18 Mar 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AUTL holding Derivative

Share Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
American Depositary Shares
Underlying amount
15,698
Exercise price
$8.38
Footnotes
F2
AUTL holding Derivative

Share Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
American Depositary Shares
Underlying amount
25,000
Exercise price
$30.24
Footnotes
F2
AUTL holding Derivative

Share Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
American Depositary Shares
Underlying amount
12,500
Exercise price
$13.25
Footnotes
F2
AUTL holding Derivative

Share Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
American Depositary Shares
Underlying amount
12,500
Exercise price
$7.57
Footnotes
F2
AUTL holding Derivative

Share Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
American Depositary Shares
Underlying amount
20,000
Exercise price
$2.84
Footnotes
F2
AUTL holding Derivative

Share Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
American Depositary Shares
Underlying amount
105,000
Exercise price
$2.38
Footnotes
F2
AUTL holding Derivative

Share Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
American Depositary Shares
Underlying amount
80,000
Exercise price
$3.48
Footnotes
F2
AUTL holding Derivative

Share Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
American Depositary Shares
Underlying amount
80,000
Exercise price
$2.32
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one ordinary share.

Footnote F2

Fully vested and exercisable.

Footnote F3

This option vested or vests in twelve equal monthly installments commencing on July 26, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .